Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.96M Buy
54,716
+3,964
+8% +$362K 0.18% 84
2026
Q1
$5.21M Buy
50,752
+4,136
+9% +$467K 0.24% 63
2025
Q4
$5.84M Sell
46,616
-530
-1% -$67.5K 0.29% 50
2025
Q3
$6.31M Buy
47,146
+1,499
+3% +$197K 0.35% 39
2025
Q2
$6.21M Buy
45,647
+7,180
+19% +$947K 0.39% 32
2025
Q1
$5.1M Buy
38,467
+5,590
+17% +$711K 0.38% 36
2024
Q4
$3.72M Buy
32,877
+4,852
+17% +$561K 0.32% 48
2024
Q3
$3.2M Buy
28,025
+5,616
+25% +$616K 0.32% 45
2024
Q2
$2.33M Buy
22,409
+3,774
+20% +$400K 0.32% 47
2024
Q1
$2.12M Buy
18,635
+1,700
+10% +$195K 0.43% 35
2023
Q4
$1.92M Buy
+16,935
New +$1.69M 0.52% 27

Other funds holding ABT

GAMMA Investing's ABT Position: Q2 2026 in Review

GAMMA Investing increased its Abbott (ABT) stake by 7.8% in Q2 2026, buying an estimated $362K and bringing the position to 54,716 shares worth $4.96M. The position accounts for 0.18% of the portfolio, ranked #84.

GAMMA Investing first reported a position in ABT in Q4 2023 and has held it in 11 quarters since. The position peaked at $6.31M in Q3 2025. 940 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • GAMMA Investing held 54,716 shares of Abbott worth $4.96M as of Q2 2026.
  • GAMMA Investing bought 3,964 Abbott shares in Q2 2026, an estimated $362K.
  • Abbott made up 0.18% of GAMMA Investing's portfolio in Q2 2026, its #84 holding.
  • GAMMA Investing first reported a position in Abbott in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Abbott position peaked at $6.31M in Q3 2025.
  • 940 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.